Plain-English translation of NCT07008365 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
When you're admitted to the hospital with acute heart failure, doctors use water pills called loop diuretics (like furosemide) to help remove excess fluid from your body. This trial is testing whether guiding the dose of this medication using two new tools—measuring pressure in your abdomen and taking ultrasound pictures of key blood vessels—might work better than the standard approach doctors use today.
Many heart failure patients leave the hospital still feeling congested and uncomfortable, even after receiving water pills. Researchers want to find better ways to measure whether the treatment is actually working so doctors can adjust doses more precisely and help patients feel better.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either receive standard water pill treatment as your doctors normally would, or receive treatment guided by abdominal pressure measurements and ultrasound images. During the first 72 hours of your hospital stay, your doctors will use these new tools to decide your medication doses. You'll need a urinary catheter in place to allow measurement of the pressure inside your abdomen, and you'll have ultrasound scans of your blood vessels to check for fluid buildup.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Spain